Tenet Healthcare Corp (THC)

Industry Medical Care Facilities

This stock can be held in an Investment ISA and an Investment Account
Sell

$148.00

Buy

$164.03

arrow-up$4.46 (+2.80%)

Tenet Healthcare Corp is a healthcare service provider in the US. The company operates acute-care hospitals that includes ambulatory surgery centers, diagnostic imaging centers, and urgent care centers across United States.
Prices updated at 15 May 2025, 23:02 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Medical Care Facilities
Chairman
Dr. Saumya Sutaria, M.D.
CEO
Dr. Saumya Sutaria, M.D.
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
98,000
Head office
14201 Dallas Parkway
Dallas
United States
75254
mobile
+1 469 893-2200
letter
InvestorRelations@tenethealth.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. J. Robert Kerrey
Lead Independent Director
0.30m--0.55m-
Dr. Meghan M. Fitzgerald, Ph.
Independent Director
0.15m--0.35m-
Mr. Richard J. Mark
Independent Director
0.14m--0.34m-
Mr. James L. Bierman
Independent Director
0.15m--0.35m-
Mr. Christopher S. Lynch
Independent Director
0.14m--0.34m-
Mr. Stephen H. Rusckowski
Independent Director
0.13m--0.33m-
Ms. Tammy Romo
Independent Director
0.17m--0.37m-
Mr. R. Scott Ramsey
Senior Vice President, Principal Accounting Officer and Controller
-----
Mr. Richard W. Fisher
Independent Director
0.16m--0.36m-
Mr. Sun Park
Executive Vice President and Chief Financial Officer
0.70m0.50m-4.70m-
Dr. Saumya Sutaria, M.D.
Chairman of the Board and Chief Executive Officer
1.50m0.50m-24.66m-
Admiral Cecil D. Haney
Independent Director
0.14m--0.34m-
Ms. Paola M Arbour
Executive Vice President and Chief Information Officer
0.55m0.50m-3.38m-
Dr. Nadja Y. West, M.D.
Independent Director
0.13m--0.33m-
Mr. Thomas W. Arnst
Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary
0.65m0.50m-5.82m-
Ms. Lisa Y. Foo
Executive Vice President, Commercial Operations
0.65m0.50m-5.16m-
Mr. Roy D. Blunt
Independent Director
0.14m--0.34m-
Dr. Vineeta Agarwala, M.D.,PhD
Independent Director
0.11m--0.31m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc9,917,6420.02412-157153-1.55986330 Apr 202510.68
BlackRock Inc9,496,4050.02683-1056210-10.00898830 Apr 202510.22
FMR Inc8,551,2760.07343129534617.85223930 Apr 20259.21
Fidelity Management and Research Company8,551,2760.07343129534617.85223930 Apr 20259.21
Fidelity Management & Research Company LLC7,719,20213.94852-33220-30 Apr 20258.31

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Oct 2024-Ms. Lisa Y. Foo155.8093,48018,966--
31 Oct 2024-Ms. Lisa Y. Foo155.96530,26415,566--
05 Sep 2024-Scott R. Ramsey162.061,879,7346,324--
27 Aug 2024-Mr. Richard W. Fisher164.04136,31714,227--
27 Aug 2024-Mr. Richard W. Fisher163.40191,01515,058--
16 Aug 2024-Ms. Paola M Arbour156.001,306,81221,426--
14 Aug 2024-Dr. Saumya Sutaria, M.D.154.3512,517,47618,902--
15 Aug 2024-Dr. Saumya Sutaria, M.D.155.36238,012---
15 Aug 2024-Dr. Saumya Sutaria, M.D.154.501,891,2351,532--
14 Aug 2024-Dr. Saumya Sutaria, M.D.155.40797,04713,773--
06 Aug 2024-Ms. Meghan M. Fitzgerald, Ph.146.342,926,80015,269--
10 Jun 2024-Mr. Richard W. Fisher132.24185,13616,227--
10 Jun 2024-Dr. Saumya Sutaria, M.D.--100,000--
10 Jun 2024-Dr. Saumya Sutaria, M.D.--271,521--
30 May 2024-Mr. J. Robert Kerrey134.651,072,35346,403--
30 May 2024-Mr. J. Robert Kerrey133.20846,88654,367--
31 May 2024-Mr. J. Robert Kerrey135.1714,058---
31 May 2024-Mr. J. Robert Kerrey134.4493,705104--
31 May 2024-Mr. J. Robert Kerrey133.301,159,577801--
30 May 2024-Mr. J. Robert Kerrey--9,500--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.